Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 4, Issue 6, 2023

The impact of anticoagulant therapy on patients with hemorrhagic stroke: a retrospective observational study from eICU database

Download as PDF

DOI: 10.23977/medsc.2023.040614 | Downloads: 2 | Views: 306

Author(s)

Lan Li 1, Xiaoxia Xie 1, Xu Zhang 1, Nan Cheng 1, Ruoxue Bai 1, Jun Chen 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710003, China

Corresponding Author

Jun Chen

ABSTRACT

The timing and effectiveness of anticoagulant therapy (AT) are controversial in patients with hemorrhagic stroke (HS). We aim to evaluate the potential impact of AT on in-hospital mortality in HS, and how this impact is influenced by the Acute Physiological and Chronic Health Evaluation (APACHE) IV score. We identified individuals with hemorrhagic stroke as the primary diagnosis (n=1654) using individual patient data from a national multicenter cohort study (eICU database; n=200859). With in-hospital mortality as the primary outcome, hemorrhagic stroke patients were split into the anticoagulant therapy group and the other treatment (OT) group. First, univariate and multivariate logistic regression analyses were conducted to identify independent predictors of in-hospital mortality in patients receiving different forms of treatment. Next, the independent predictor's interaction with the AT status was evaluated.Resultly, 8.3%(n=137) of patients were in AT group. The survival rate in the AT group was significantly higher than that in the OT group (87.6% vs. 78.8%; P < 0.05). AT was an independent predictor of in-hospital mortality risk in the entire cohort [OR= 0.542, 95%CI(0.298-0.985), P<0.05], and APACHE IV score [OR= 1.055, 95%CI(1.048-1.061), P<0.05] score was an independent predictor of in-hospital mortality in the OT group in multivariate logistic regression (P< 0.05). The APACHE IV score was used to predict the risk for the entire cohort (the area under the receiver operator characteristic curve was 0.825 [(95% CI (0.799-0.851)]. Patients who started anticoagulant therapy seemed to benefit more when the predicted in-hospital mortality risk was more than 6.9%, and patients without anticoagulant therapy seemed to benefit more when the predicted in-hospital mortality risk was less than 6.9%. In conclusion, patients diagnosed with hemorrhagic stroke benefit from AT. APACHE IV score has a better ability to predict in-hospital mortality risk. Specifically, the higher the predicted risk of in-hospital mortality, the greater the benefits of anticoagulant therapy.

KEYWORDS

Hemorrhagic stroke; Anticoagulant therapy; APACHE IV score

CITE THIS PAPER

Lan Li, Xiaoxia Xie, Xu Zhang, Nan Cheng, Ruoxue Bai, Jun Chen, The impact of anticoagulant therapy on patients with hemorrhagic stroke: a retrospective observational study from eICU database. MEDS Clinical Medicine (2023) Vol. 4: 91-99. DOI: http://dx.doi.org/10.23977/medsc.2023.040614.

REFERENCES

[1] Murthy SB, Zhang C, Diaz I, Levitan EB, Koton S, Bartz TM, et al. Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort Studies [J]. JAMA neurology, 2021, 78(7):809-816.
[2] Van Nieuwenhuizen KM, Vaartjes I, Verhoeven JI, Rinkel GJ, Kappelle LJ, Schreuder FH, et al. Long-term prognosis after intracerebral haemorrhage [J]. European stroke journal, 2020, 5(4):336-344.
[3] Li L, Poon MTC, Samarasekera NE, Perry LA, Moullaali TJ, Rodrigues MA, et al. Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies [J]. The Lancet Neurology, 2021, 20(6):437-447.
[4] Simard JM, Aldrich EF, Schreibman D, James RF, Polifka A, Beaty N. Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: A preliminary assessment [J]. Journal of Neurosurgery, 2013, 119(6): 1611-1619.
[5] Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors [J]. Stroke, 2009, 40(6):2068-2072.
[6] Horstmann S, Rizos T, Jenetzky E, Gumbinger C, Hacke W, Veltkamp R. Prevalence of atrial fibrillation in intracerebral hemorrhage [J]. European journal of neurology, 2014, 21(4):570-576.
[7] Arboix A, García-Eroles L, Vicens A, Oliveres M, Massons J. Spontaneous primary intraventricular hemorrhage: clinical features and early outcome [J]. ISRN neurology, 2012, 2012: 498303.
[8] Khurram A, Kleinig T, Leyden J. Clinical associations and causes of convexity subarachnoid hemorrhage [J]. Stroke, 2014, 45(4): 1151-1153.
[9] Santarius T, Kirkpatrick PJ, Ganesan D, Chia HL, Jalloh I, Smielewski P, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial [J]. Lancet, 2009, 374(9695):1067-1073.
[10] Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study [J]. European heart journal, 2012, 33(12):1500-1510.
[11] Brønnum Nielsen P, Larsen TB, Gorst-Rasmussen A, Skjøth F, Rasmussen LH, Lip GYH. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study [J]. Chest, 2015, 147(6):1651-1658.
[12] Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J]. Circulation, 2017, 135(25):e1159-e95.
[13] Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage [J]. International journal of stroke: official journal of the International Stroke Society, 2014, 9(7):840-855.
[14] Hemphill JC, 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J]. Stroke, 2015, 46(7):2032-2060.
[15] Bennett CE, Wright RS, Jentzer J, Gajic O, Murphree DH, Murphy JG, et al. Severity of illness assessment with application of the APACHE IV predicted mortality and outcome trends analysis in an academic cardiac intensive care unit [J]. J Crit Care, 2019, 50:242-246.
[16] Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients [J]. Crit Care Med, 2006, 34(5):1297-1310.
[17] Cho DY, Wang YC. Comparison of the APACHE III, APACHE II and Glasgow Coma Scale in acute head injury for prediction of mortality and functional outcome [J]. Intensive care medicine, 1997, 23(1):77-84.
[18] Moon BH, Park SK, Jang DK, Jang KS, Kim JT, Han YM. Use of APACHE II and SAPS II to predict mortality for hemorrhagic and ischemic stroke patients [J]. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia, 2015, 22(1):111-115.
[19] Pollard TJ, Johnson AEW, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU Collaborative Research Database, a freely available multi-center database for critical care research [J]. Sci Data, 2018, 5:180178.
[20] O'Halloran HM, Kwong K, Veldhoen RA, Maslove DM. Characterizing the Patients, Hospitals, and Data Quality of the eICU Collaborative Research Database [J]. Crit Care Med, 2020, 48(12):1737-1743.
[21] Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies [J]. Multivariate behavioral research, 2011, 46(3):399-424.
[22] Biffi A, Kuramatsu JB, Leasure A, Kamel H, Kourkoulis C, Schwab K, et al. Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage [J]. Annals of neurology, 2017, 82(5):755-765.    
[23] Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation [J]. European heart journal, 2018, 39(16):1330-1393.
[24] Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY. Restarting Anticoagulant Treatment after Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study [J]. Circulation, 2015, 132(6):517-525.
[25] Kuramatsu JB, Sembill JA, Gerner ST, Sprügel MI, Hagen M, Roeder SS, et al. Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves [J]. European heart journal, 2018, 39(19): 1709-1723.
[26] Choi JW, Park YS, Lee YS, Park YH, Chung C, Park DI, et al. The Ability of the Acute Physiology and Chronic Health Evaluation (APACHE) IV Score to Predict Mortality in a Single Tertiary Hospital [J]. Korean J Crit Care Med, 2017, 32(3):275-283.
[27] Vandenbrande J, Verbrugge L, Bruckers L, Geebelen L, Geerts E, Callebaut I, et al. Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients [J]. Critical care research and practice, 2021, 2021: 5443083.
[28] Shrope-Mok SR, Propst KA, Iyengar R. APACHE IV versus PPI for predicting community hospital ICU mortality [J]. The American journal of hospice & palliative care, 2010, 27(4):243-247.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4708
Visits: 205364

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.